Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
11/2006
11/15/2006EP1720613A2 Fused tricyclic compounds as inhibitors of 17beta-hydroxysteroid dehydrogernase 3
11/15/2006EP1720553A1 Pyrimidine compounds as purine receptor antagonist
11/15/2006EP1562907B1 Pyridine derivatives as cb2 receptor modulators
11/15/2006EP1539746B1 N-substituted-1h-indol-5-propionic acid compounds as ppar agonists useful for the treatment of diabetes
11/15/2006EP1401434B1 Modulators of peroxisome proliferator activated receptors (ppar)
11/15/2006EP1324991B1 Compounds useful in the treatment of inflammatory diseases
11/15/2006EP0968206B1 N-heterocyclic derivatives as nos inhibitors
11/15/2006CN1863800A Novel compounds that modulate PPAR type receptors, and use thereof in cosmetic or pharmaceutical compositions
11/15/2006CN1863799A Chroman carboxylic acid derivatives for the treatment of diabetes and lipid disorders
11/15/2006CN1863797A Cyclic amine BACE-1 inhibitors having a benzamide substituent
11/15/2006CN1863790A Therapeutic agents useful for treating pain
11/15/2006CN1863785A Compositions useful as inhibitors of voltage-gated sodium channels
11/15/2006CN1863782A 2-(quinoxalin-5-ylsulfonylamino)-benzamide compounds as cck2 modulators
11/15/2006CN1863781A 2-(quinoxalin-5-ylsulfonylamino)-benzamide compounds as cck2 modulators
11/15/2006CN1863778A Compounds and methods for treating dyslipidemia
11/15/2006CN1863770A Cyclic amine BASE-1 inhibitors having a heterocyclic substituent
11/15/2006CN1863530A (3,4-phenyl)piperidin-3-yl- phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
11/15/2006CN1863528A Indoles and azaindoles as antiviral agents
11/15/2006CN1863459A 2,6 substituted pyridine-3-carbonyl derivatives serving as plant protection agents having herbicidal action
11/15/2006CN1284780C 8'4-'3-(5-fluoro-1H-indol-3-yl)propyl!-1-piperazinyl!-2-methyl-2H-1,4-benzoxazin -3(4H)-one methanesulfonate with high affinity for the dopamine D2 receptor and the seotonin reuptake site
11/14/2006US7135575 P38 inhibitors and methods of use thereof
11/14/2006US7135495 Indole derivatives
11/14/2006US7135490 Method for the treatment of glomerulonephritis
11/14/2006US7135486 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
11/14/2006US7135484 Azabicyclic compounds are central nervous system active agents
11/14/2006US7135473 Cyclic diamine compound with condensed-ring groups
11/14/2006US7135472 3-Heterocyclic benzylamide derivatives as potassium channel openers
11/14/2006US7135469 Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors
11/14/2006US7135468 Antibacterial compounds
11/14/2006US7135467 HIV integrase inhibitors
11/14/2006CA2274669C 1,5-benzodiazepine derivatives
11/14/2006CA2244363C Synthetic derivatives of rapamycin as multimerizing agents for chimeric proteins with immunophilin-derived domains
11/14/2006CA2171836C Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
11/12/2006CA2546392A1 Phenylpyridinylpiperazine derivatives, a process for their preparation and pharmaceutical compositions containing them
11/12/2006CA2546387A1 Phenyl-pyridinyl-piperazine derivatives, process for the preparation thereof and pharmaceutical compositions containing said derivatives
11/09/2006WO2006117760A1 Adrenergic receptor antagonists
11/09/2006WO2006117653A1 Azole-based phosphodiesterase inhibitors
11/09/2006WO2006117552A1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
11/09/2006WO2006117305A1 (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-ht receptor
11/09/2006WO2006117211A2 Urea derivatives methods for their manufacture and uses thereof
11/09/2006WO2006117183A1 3 -m0n0- and 3 , 5-disubstituted piperidine derivatives as renin inhibitors
11/09/2006WO2006072828A3 Heteroaromatic quinoline compounds and their use as pde10 inhibitors
11/09/2006WO2006057945A3 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
11/09/2006WO2005079802A8 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
11/09/2006US20060252932 Isolated bis-linezolid, preparation thereof, and its use as a reference standard
11/09/2006US20060252799 Benzo (F) insoindol derivatives and their use as EP4 receptor ligands
11/09/2006US20060252795 Chemokine receptor binding heterocyclic compounds
11/09/2006US20060252778 Compounds for the treatment of inflammatory disorders
11/09/2006US20060252768 2,3,6-Trisubstituted-4-pyrimidone derivatives
11/09/2006US20060252767 Piperazine derivatives and their use as therapeutic agents
11/09/2006US20060252766 Methods using a combination of 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia
11/09/2006US20060252764 HIV inhibiting pyrimidines derivatives
11/09/2006US20060252752 Octahydrocyclopenta[b]pyrrole-sulfonamide-2-carboxylic acid derivatives; reduced side effects
11/09/2006US20060252751 specific compound N-(2-{[(3R)-1-(4-hydroxy-4-pyrimidin-4-ylcyclohexyl)pyrrolidin-3-yl]amino}-2-oxoethyl)-3-(trifluoromethyl)benzamide; multiple sclerosis; CCR2 and/or CCR5 antagonists
11/09/2006US20060252747 Substitituted 1-piperidin-3-yl-piperidin 4-yl-piperazine derivatives and their use as neurokinin auantagonists
11/09/2006US20060252741 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
11/09/2006US20060252673 Synergistic combinations with morphine; analgesics and cyclooxygenase-2 inhibitors, such as N-5-guanidinopentanamide-(2S)-yl-2-N-(p-hydroxyphenylacetyl)phenylenediamine and N-5-guanidinopentanamide-(2R)-yl-2-N-(p-hydroxybenzyl)-5-carboxybenzimidazole
11/09/2006US20060252093 Heterocyclic organic molecules through intramolecular formation of n-acyliminium ions
11/09/2006CA2607227A1 (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-ht receptor
11/09/2006CA2606538A1 3 -m0n0- and 3 , 5-disubstituted piperidine derivatives as renin inhibitors
11/09/2006CA2606338A1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
11/09/2006CA2605008A1 Urea derivatives, methods for their manufacture, and uses therefor
11/08/2006EP1719763A1 Novel pyridine derivative and pyrimidine derivative (2)
11/08/2006EP1719762A1 Novel pyridine derivative and pyrimidine derivative (1)
11/08/2006EP1719761A1 Novel heterocyclic compound
11/08/2006EP1718641A2 Benzimidazole derivative and its use as aii receptor antagonist
11/08/2006EP1718632A1 Pyrimidine derivatives as orexin receptor antagonists
11/08/2006EP1718625A1 Compounds
11/08/2006EP1718616A2 Isoquinoline derivatives
11/08/2006EP1718615A1 Novel quinoline-carbaxamides as jack3 kinase modulators
11/08/2006EP1718608A1 Viral polymerase inhibitors
11/08/2006EP1718307A2 Immunosuppressant compounds and compositions
11/08/2006EP1718305A1 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
11/08/2006CN1860117A Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
11/08/2006CN1860115A Process for the preparation of chiral propionic acid derivatives
11/08/2006CN1860114A Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments
11/08/2006CN1860113A Nicotinamide derivatives useful as PDE4 inhibitors
11/08/2006CN1860107A Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof
11/08/2006CN1859914A Phenyl pyrrolidine ether tachykinin receptor antagonists
11/08/2006CN1283638C Indole-2-formamide compounds as factor Xa inhibitors
11/08/2006CN1283626C Substituted benzene derivatives or salts thereof
11/08/2006CN1283252C Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives for reducing ischaemic damage
11/07/2006US7132551 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimer*s, Parkinson*s, Lesche-Nyhane, Wilson*s, and Tourette*s syndrome
11/07/2006US7132542 Compounds for the treatment of male erectile dysfunction
11/07/2006US7132534 Para-phenylenediamine derivatives containing a pyrrolidyl group, and use of these derivatives for coloring keratin fibers
11/07/2006US7132445 Antiinflammatory agents; anticancer agents; analgesics; antiarthritic agents; inflammatory bowel disorders; respiratory system disorders
11/07/2006US7132443 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
11/07/2006US7132439 Bis-benzimidazoles and related compounds as potassium channel modulators
11/07/2006US7132432 Antiinflammatory agents; vision defects; autoimmune diseases; hepatitis; cardiovascular disordersl chronic fatigue syndromel chronic ostructive pulmonary disease; congestive heart failure
11/07/2006US7132427 Quinazolines and uses thereof
11/07/2006US7132425 5-substituted-six-membered heteroaromatic glucokinase activators
11/07/2006US7132424 Monocyclic derivatives as matrix metalloproteinase inhibitors
11/07/2006US7132423 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
11/07/2006US7132420 Aspartic protease inhibitors
11/07/2006CA2146961C Heterobicyclic sulfonamide and sulfonic ester derivatives
11/07/2006CA2132132C Process for the preparation of 3-arylbenzofuranones
11/02/2006WO2006116713A1 Substituted amide derivatives as protein kinase inhibitors
11/02/2006WO2006116614A1 Benzisoxazole piperidine compounds and methods of use thereof
11/02/2006WO2006116563A1 Vanilloid receptor ligands and their use in treatments
11/02/2006WO2006116526A2 Polymorph form ii of tanaproget